Follow
Yeng Ang
Yeng Ang
University of Manchester
Verified email at srft.nhs.uk
Title
Cited by
Cited by
Year
The repertoire of mutational signatures in human cancer.
Nature 578 (7793), 94-101, 2020
23382020
pan-cancer analysis of whole genome
ITP consortium
Nature 578, 82-93, 2020
1672*2020
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus
RC Fitzgerald, M Di Pietro, K Ragunath, Y Ang, JY Kang, P Watson, ...
Gut 63 (1), 7-42, 2014
14832014
The evolutionary history of 2,658 cancers
M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ...
Nature 578 (7793), 122-128, 2020
8352020
Patterns of somatic structural variation in human cancer genomes
Nature 578 (7793), 112-121, 2020
6762020
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis
GF Mells, JAB Floyd, KI Morley, HJ Cordell, CS Franklin, SY Shin, ...
Nature genetics 43 (4), 329-332, 2011
5332011
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
I Cortés-Ciriano, JJK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ...
Nature genetics 52 (3), 331-341, 2020
5262020
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
E Rheinbay, MM Nielsen, F Abascal, JA Wala, O Shapira, G Tiao, ...
Nature 578 (7793), 102-111, 2020
4972020
Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid
M Carbone, GF Mells, G Pells, MF Dawwas, JL Newton, MA Heneghan, ...
Gastroenterology 144 (3), 560-569. e7, 2013
4282013
ordering of mutations in preinvasive disease stages of esophageal carcinogenesis
O Consortium.
nature genetics 46 (8), 837-43, 2014
3732014
The UK-PBC risk scores: Derivation and validation of a scoring system for long term prediction of bed stage liver disease in primary biliary cirrhosis
et al Carbone M, Sharp SJ, Flack S
Hepatology, 2015
370*2015
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance
M Secrier, X Li, N De Silva, MD Eldridge, G Contino, J Bornschein, ...
Nature genetics 48 (10), 1131-1141, 2016
3522016
The management of gastric polyps
AF Goddard, R Badreldin, DM Pritchard, MM Walker, B Warren
Gut 59 (9), 1270-1276, 2010
3202010
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
PRD Dutton SJ, Ferry DR, Blazeby JM, Abbas H, Dahle-Smith A, Mansoor W ...
lancet oncology 15 (8), 894-904, 2014
3172014
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
B Rodriguez-Martin, EG Alvarez, A Baez-Ortega, J Zamora, F Supek, ...
Nature genetics 52 (3), 306-319, 2020
3092020
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis
JZ Liu, MA Almarri, DJ Gaffney, GF Mells, L Jostins, HJ Cordell, SJ Ducker, ...
Nature genetics 44 (10), 1137-1141, 2012
3012012
international genome wide meta analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
et al Cordell HJ, Han Y, Mells CF
Nature Communications, 2015
2962015
Whole Genome sequencing provides new insights into the coronal architecture of Barrett's esophagus and esophageal adenorcarcinoma
WA Ross-Innes CS, Becq J
Nature Genetics 47 (9), 1038-46, 2015
2962015
Comprehensive molecular characterization of mitochondrial genomes in human cancers
Y Yuan, YS Ju, Y Kim, J Li, Y Wang, CJ Yoon, Y Yang, I Martincorena, ...
Nature genetics 52 (3), 342-352, 2020
2912020
Genomic basis for RNA alterations in cancer
PTC Group, PTW Group, ...
Nature 578 (7793), 129-136, 2020
271*2020
The system can't perform the operation now. Try again later.
Articles 1–20